Stonegate Capital Partners Updates Coverage On GoHealth Inc. (GOCO) 2025 Q1
GoHealth Inc. (NASDAQ: GOCO) reported strong financial results for Q1 2025, with net revenues increasing 19.1% year-over-year to $221.0 million. The company demonstrated significant operational improvements, achieving a 40.2% increase in submissions to 303,026 compared to 216,148 in Q1 2024.
The Medicare-focused digital health marketplace provider posted an operating income of $6.7 million, marking a notable turnaround from the previous year's loss. Additionally, Adjusted EBITDA grew by 56.4% to $45.1 million. During the quarter, GoHealth also announced the launch of its new product, GoHealth Protect.
GoHealth Inc. (NASDAQ: GOCO) ha riportato risultati finanziari solidi per il primo trimestre del 2025, con ricavi netti in aumento del 19,1% su base annua, raggiungendo 221,0 milioni di dollari. L'azienda ha mostrato significativi miglioramenti operativi, registrando un incremento del 40,2% nelle sottomissioni, arrivando a 303.026 rispetto alle 216.148 del primo trimestre 2024.
Il fornitore di un marketplace digitale focalizzato su Medicare ha registrato un reddito operativo di 6,7 milioni di dollari, segnando un importante miglioramento rispetto alla perdita dell'anno precedente. Inoltre, l'EBITDA rettificato 猫 cresciuto del 56,4%, raggiungendo 45,1 milioni di dollari. Nel corso del trimestre, GoHealth ha anche annunciato il lancio del suo nuovo prodotto, GoHealth Protect.
GoHealth Inc. (NASDAQ: GOCO) report贸 s贸lidos resultados financieros para el primer trimestre de 2025, con ingresos netos que aumentaron un 19,1% interanual hasta 221,0 millones de d贸lares. La compa帽铆a mostr贸 mejoras operativas significativas, logrando un aumento del 40,2% en las presentaciones, alcanzando 303.026 en comparaci贸n con las 216.148 del primer trimestre de 2024.
El proveedor del mercado digital enfocado en Medicare registr贸 un ingreso operativo de 6,7 millones de d贸lares, marcando una notable recuperaci贸n respecto a la p茅rdida del a帽o anterior. Adem谩s, el EBITDA ajustado creci贸 un 56,4% hasta 45,1 millones de d贸lares. Durante el trimestre, GoHealth tambi茅n anunci贸 el lanzamiento de su nuevo producto, GoHealth Protect.
GoHealth Inc. (NASDAQ: GOCO)電� 2025雲� 1攵勱赴 臧曤牓頃� 鞛 鞁れ爜鞚� 氚滍憸頄堨溂氅�, 靾滊Г於滌澊 鞝勲厔 雽�牍� 19.1% 歃濌皜頃� 2鞏� 2,100毵� 雼煬毳� 旮半頄堨姷雼堧嫟. 須岇偓電� 鞖挫榿 須湪靹膘潉 韥矊 臧滌劆頃橃棳, 2024雲� 1攵勱赴 216,148瓯� 雽�牍� 鞝滌稖 瓯挫垬臧� 40.2% 歃濌皜頃� 303,026瓯�鞚� 雼劚頄堨姷雼堧嫟.
氅旊敂旒�鞏� 欷戩嫭鞚� 霐旍韯� 項姢 毵堨紦頂岆爤鞚挫姢 鞝滉车鞐呾泊鞚� 鞚� 須岇偓電� 鞓侅梾鞚挫澋 670毵� 雼煬毳� 旮半頃橂┌ 鞝勲厔霃� 鞝侅瀽鞐愳劀 雸堨棎 霛勲姅 氚橃爠鞚� 鞚措（鞐堨姷雼堧嫟. 霕愴暅, 臁办爼 EBITDA電� 56.4% 歃濌皜頃� 4,510毵� 雼煬毳� 旮半頄堨姷雼堧嫟. 攵勱赴 欷� GoHealth電� 鞁犾牅頀堨澑 GoHealth Protect 於滌嫓霃� 氚滍憸頄堨姷雼堧嫟.
GoHealth Inc. (NASDAQ : GOCO) a publi茅 de solides r茅sultats financiers pour le premier trimestre 2025, avec des revenus nets en hausse de 19,1 % sur un an, atteignant 221,0 millions de dollars. La soci茅t茅 a d茅montr茅 des am茅liorations op茅rationnelles significatives, r茅alisant une augmentation de 40,2 % des soumissions, soit 303 026 contre 216 148 au premier trimestre 2024.
Le fournisseur de place de march茅 num茅rique ax茅 sur Medicare a affich茅 un r茅sultat d'exploitation de 6,7 millions de dollars, marquant un retournement notable par rapport 脿 la perte de l'ann茅e pr茅c茅dente. De plus, l'EBITDA ajust茅 a augment茅 de 56,4 % pour atteindre 45,1 millions de dollars. Au cours du trimestre, GoHealth a 茅galement annonc茅 le lancement de son nouveau produit, GoHealth Protect.
GoHealth Inc. (NASDAQ: GOCO) meldete starke Finanzergebnisse f眉r das erste Quartal 2025 mit einem Netto-Umsatzanstieg von 19,1 % im Jahresvergleich auf 221,0 Millionen US-Dollar. Das Unternehmen zeigte deutliche operative Verbesserungen und erreichte eine Steigerung der Einreichungen um 40,2 % auf 303.026 im Vergleich zu 216.148 im ersten Quartal 2024.
Der auf Medicare fokussierte digitale Gesundheitsmarktplatz verzeichnete ein Operatives Ergebnis von 6,7 Millionen US-Dollar, was eine bemerkenswerte Wende gegen眉ber dem Verlust des Vorjahres darstellt. Zudem stieg das bereinigte EBITDA um 56,4 % auf 45,1 Millionen US-Dollar. Im Quartal k眉ndigte GoHealth au脽erdem die Einf眉hrung seines neuen Produkts GoHealth Protect an.
- Net revenues increased 19.1% YoY to $221.0M
- Submissions grew 40.2% YoY to 303,026
- Operating income turned positive at $6.7M from previous year's loss
- Adjusted EBITDA increased 56.4% to $45.1M
- Launch of new product GoHealth Protect
- None.
Dallas, Texas--(Newsfile Corp. - May 14, 2025) - GoHealth Inc. (NASDAQ: GOCO): Stonegate Capital Partners updates their coverage on GoHealth Inc. (NASDAQ: GOCO). GoHealth, Inc. delivered a strong first quarter in 2025, highlighted by substantial revenue growth and operational efficiencies. Net revenues surged
To view the full announcement, including downloadable images, bios, and more, .
Key Takeaways:
- First quarter 2025 net revenues of
$221.0 million , a19.1% increase compared to$185.6 million in the prior year period. - First Quarter Submissions were 303,026, a
40.2% increase compared to 216,148 Submissions. - The Company announced the launch of GoHealth Protect in the quarter.
Click image above to view full announcement.
About Stonegate
Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies.
Contacts:
Stonegate Capital Partners
(214) 987-4121
[email protected]
Source:
To view the source version of this press release, please visit
FAQ
What were GoHealth's (GOCO) Q1 2025 earnings results?
How many submissions did GOCO process in Q1 2025?
What new product did GoHealth (GOCO) launch in Q1 2025?
How much did GoHealth's (GOCO) Adjusted EBITDA grow in Q1 2025?
